alexa Interview | Victor ChabannbspJournal of Autacoids and H
ISSN: 2161-0479

Journal of Autacoids and Hormones
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Victor Chaban
Victor Chaban

Executive Editor
Victor Chaban
Associate Professor of Medicine
University of California
Los Angeles
Read Interview session with Victor Chaban


 Dr. Chaban received his Ph.D. from Bogomoletz Institute, Kiev and continued his training at Babraham Institute, Cambridge, U.K. He completed his post-doctoral training in Neuroscience at the Department of Medicine at University of California, Los Angeles and graduate training in Clinical Research at Charles Drew University of Medicine and Science. Currently Dr. Chaban is an Associate Professor of Medicine. He received Wood-Whellan Award from International Union of Biochemistry and Molecular Biology and Fellowships from European Science Foundation and UNESCO as well as NIH grants. He also received President\\s Award for Excellence in Service to Charles Drew University and Life Sciences Institute Emerging Scientist Award. Dr. Chaban is Director, Clinical and Translational Research Center; "Accelerating Excellence in Translational Science" (AXIS) and Co-Leader of Educational Core of UCLA Clinical and Translational Science Institute. He serves as Editor of Bioscience and International Journal of Research in Nursing. He is also a member of  National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel- ZDK1-GRB Study Section.

Research Interest

The primary focus of my research program is to elucidate the nociceptive pathways modulated by circulating and local hormones in nervous tissue. While a central site of this modulation has been widely accepted, I have continued to investigate how they act on primary nociceptors and modulate the response to pro- and anti-nociceptive signals, depending upon the nature of the signals interacting at the level of sensory neurons. Nociceptive systems are implicated in the etiology of functional disorders such as non- cardiac chest pain, interstitial cystitis, fibromyalgia, acute or chronic abdominal pain associated with functional bowel disorders, chronic pelvic pain and others. Our studies may provide important information about the actions of hormones on primary sensory neurons for a better understanding  the clinical presentation of functional pain-associated disorders.



1. How many years have you been associated with the current research?
More than 2 decades

2. What is the research topic you are working on now?
Role of sex steroids and other local hormones (autacoids) on modulation of visceral pain in different models of nociception and clinical aspects of functional and other disorders.

3. What are attributes for a quality article?
Novelty, originality, impact

4. Do you have any research funding (NIH or other national funding) now?
National Institute of neurological Disorders and Stroke grant NS063939 (active)

5. When did you become an editor of OMICS Journal?

6. Where can the journal find the maximum scope in terms of niche?
Research and medical communities, industry

7. What is your greatest career accomplishment?
Program Director- U54 NIH center of excellence ($14M budget).

8. How does the published scientific content assist the potential researchers?
By guiding their future research development

9. What is the purpose of serving as an editor?
To help promote JAC and serve in reviewing/editing manuscripts, managing submission process

10. Do you have any patents?
Yes, US Patent (pending)

11. Have you contributed any editorials or papers (any types) to OMICS Journals in the past two years?

12. Do you plan to contribute any editorials or papers to OMICS Journals in the next year?

13. How would you define your experience with OMICS Group?

14. Your opinion on conducting Editorial Board meetings at related Conferences?
Would be helpful- I will try on the 2nd International Conference on Endocrinology and others

15. Would you recommend OMICS to your friends or colleagues?
Yes, I am doing now

16. How do you differentiate Journal of Autacoids with other journals in the field?
Emerging with great potential